Aldh1-expressing cells increase in number and are spatially associated with endocrine cells during secondary islet formation.

Expression of Aldh1 (red arrows) is compared with that of Insulin (white arrows), as assessed immunofluorescent labeling at 5 (A), 10 (B), 15 (C), 20 (D), 25 (E) and 30 dpf (F). (G) Quantification of the number of Aldh1-expressing cells located outside of the principle islet (black line), and their juxtaposition with Insulin-expressing cells (grey line). Values were derived from n=10 fish per developmental time point, with a minimum of 3 sections per fish. (*) and (**) indicate p<0.05 and p<0.01, respectively. Dotted white lines in (A) and (B) indicate region of principle islet; dotted white lines in (D) and (E) indicate region of pancreatic duct.

Aldh1 is expressed in NeuroD^pos endocrine progenitor cells.

Expression of Aldh1 is compared with that of Pax6b:eGFP (pan-endocrine cell marker; A-D), Hb9:eGFP (early β cell marker; E-H) and NeuroD:eGFP (endocrine progenitor marker; I-L) at 15 (A, E and I), 20 (B, F and J), 25 (C, G and K) and 30 dpf (D, H and L). Note that Aldh1 is co-expressed with eGFP in NeuroD:eGFP fish (arrows), but not in Pax6b:eGFP and Hb9:eGFP fish. Dotted white lines in (E) indicate region of principle islet.

Aldh1-expressing cells express the pancreatic epithelial marker 2F11.

(A-D) All Aldh1-expressing cells co-express the pancreatic epithelial marker 2F11 (white arrows). (E) 2F11 does not label GRCFP^pos vascular endothelial cells in Kdrl:GRCFP fish. (F-H) 2F11 labels both a subset of Insulin^pos cells (G and G′) and eGFP^pos cells in NeuroD:eGFP (F and F′), Pax6b:eGFP (G and G′) Hb9:eGFP (H) fish. White arrows in A-D indicate cells co-labeling for both 2F11 and Aldh1. White arrows in F and F′ indicate Insulin-negative cells co-expressing 2F11, Aldh1 and NeuroD:eGFP. White arrows in G and G′ indicate Aldh1-negative cell co-expressing Insulin, 2F11 and Pax6:eGFP. White arrow in H indicates Aldh1-negative cell expressing Insulin, 2F11 and Hb9:eGFP; blue arrows indicate Insulin-negative, Hb9:eGFP-negative cells expressing 2F11 and Aldh1.

Cell proliferation among Aldh1- and 2F11-expressing cells.

EdU signals (white arrows) were detected in subsets 2F11^pos cells at 15 (A), 20 (B) and 25 dpf (C). (D) Cells co-expressing Aldh1 and 2F11 (blue arrows) are not proliferative, but are localized in the adjacent to Aldh1-negative, EdU^pos, 2F11^pos cells (white arrows). (E and E′) Cells co-expressing NeuroD and 2F11 (yellow arrows) are not proliferative but are localized adjacent to NeuroD:eGFP-negative, EdU^pos, 2F11^pos cells (white arrows). (F and F′) Detailed geometry of 2F11, Aldh1, NeuroD:eGFP expression in association with EdU incorporation. White arrows indicate EdU ^pos/2F11 ^pos/Aldh1 ^neg/NeuroD:eGFP^neg cells. Blue arrows indicate EdU^neg /2F11 ^pos/Aldh1 ^pos/NeuroD:eGFP^pos cells. Yellow arrows indicate EdU ^neg/2F11 ^pos/Aldh1 ^neg/NeuroD:eGFP^pos cells. Green arrows indicate EdU ^neg/2F11^neg /Aldh1 ^neg/NeuroD:eGFP^pos cells.

Aldh1-expressing cells are derived from Notch-responsive progenitor cells.

(A) Schematic timeline for 4OHT-induced lineage labeling. Tp1bglob:CreER ^T2/βactin:loxp-stop-loxp-hmgb-mCherry fish were treated with either 1% EtOH (B and D; negative controls) or with 4-hydroxy-tamoxifen (4OHT) between either 3-5 dpf (B and C) or 18-20 dpf (D and E), and then sacrificed for analysis at 25 dpf. Cells carrying the Tp1bglob:CreER^T2 lineage label display red nuclei. (C) 2F11 ^pos/Aldh1^pos cells arise from Notch-responsive cells labeled between 3-5 dpf (blue arrows). (E) Notch-responsive cells labeled between 18-20 dpf give rise to Aldh1^pos (blue arrows), Pax6:eGFP+ endocrine cells (green arrows) and ductal cells (white arrows). F, Schematic depiction of proposed lineage relationships between Notch-responsive progenitors (Notch-ON) and cells expressing 2F11, Aldh1, NeuroD and Pax6b during secondary islet formation. Notch-ON cells expressing 2F11 (red) give rise to Notch-OFF, 2F11^pos, NeuroD^pos, Aldh1^pos cells (blue), which then inactivate Aldh1 and activate Pax6 expression (green) prior to undergoing terminal endocrine differentiation (orange).

Inhibition of Aldh1 enzymatic activity increases the number of Aldh1- and NeuroD-expressing endocrine progenitor cells and induces their premature differentiation.

Panels to the right of merged images represent corresponding single channel images. (A and B) NeuroD:eGFP/Tp1:hmgb-mCherry fish were treated with DMSO (A) or DEAB (B) at 72-120 hpf. DEAB treatment increased the number of Notch-responsive cells also expressing NeuroD:eGFP (red arrows). (C) Quantification of the number of eGFP^pos and/or mCherry^pos cells in 1000 µm³ of 2F11^pos tissue in NeuroD:eGFP/Tp1:hmgb-mCherry fish treated with DMSO or DEAB between 72-120 hpf. Inhibition of Aldh1a induced NeuroD:eGFP expression in Notch-responsive cells. Values indicate mean + SEM, with minimum of 20 larvae analyzed for each condition. (*) indicates p<0.05. (D) Quantification of the number of Aldh1-expresing cells in 100,000 μm³ of 2F11^pos tissue in NeuroD:eGFP/Tp1:hmgb-mCherry fish treated with DMSO or DEAB treatment between 72-120 hpf. Values indicate mean + SEM, with minimum of 20 larvae analyzed for each condition. (*) indicates p<0.05. (E and F) NeuroD:eGFP/Tp1:hmgb-mCherry fish were treated with DMSO (E) or DEAB (F) at 18-20 dpf. DEAB treatment increased the number of Notch-responsive cells also expressing NeuroD:eGFP (red arrows), and these cells were frequently adjacent to Aldh1-expressing cells (blue arrows). (G and H) Pax6b:eGFP/Tp1:hmgb-mCherry fish were treated with DMSO (G) or DEAB (H) between 18-20 dpf. DEAB treatment activated Pax6:eGFP expression in Aldh1-expressing cells. (I) Quantification of number of eGFP^pos and/or mCherry^pos cells in 1000 µm² of 2F11^pos tissue in NeuroD:eGFP/Tp1:hmgb-mCherry or Pax6b:eGFP/Tp1:hmgb-mCherry fish treated with DMSO or DEAB between 18-20 dpf. NeuroD:eGFP, but not Pax6:eGFP expression is activated within Notch responsive cells following DEAB treatment. In contrast, Pax6:eGFP but not NeuroD:eGFP expression is induced in cells not expressing Tp1:hmgb1-mCherry. (*) indicates p<0.05, with n=8 fish per condition and a minimum of 3 sections analyzed per fish. (J) Quantification of Aldh1-expressing cells also expressing either NeuroD:eGFP or Pax6:eGFP following treatment with either DMSO or DEAB between 18-20 dpf. DAEB treatment increases the number of cells Aldh1-expressing cells also expressing either NeuroD:eGFP or Pax6:eGFP. (*) and (**) indicates p<0.05 and p<0.01, respectively. n=10 fish per condition and a minimum of three sections analyzed per fish.

Aldh1-expressing cells are distinct from Notch-responsive cells. (A, A′, B and B′) Notch responsive cells (Tp1:mCherry; white arrows) also express 2F11 at 20 (A and A′) and 25 dpf (B and B′). (C, C′, D and D′) Cells co-expressing Tp1:eGFP and 2F11^pos are proliferative (white arrows). (E) At 20 dpf, Aldh1^pos cells (blue arrows) are a distinct from Notch-responsive cells (red arrows), but are sometimes localized adjacent to Notch-responsive cells in the ductal epithelium. All images acquired from fish at 20-25dpf.

Aldh1-expressing cells and Notch-responsive cells represent distinct cell types in adult zebrafish pancreas. (A-D) FACS sorting was performed on single cells isolated from adult pancreas of wild type (A and B) or Tp1:eGFP (C and D) fish. Wild-type cells were labeled with Aldefluor and then FACS sorted, while cells from Tp1:eGFP fish were sorted for eGFP. Sorted populations were then subjected to cytospin and immunofluorescent labeling for Aldh1. In the case of cells from Tp1:eGFP fish, labeling was also performed for eGFP. Note that Aldh1 protein is detected in Aldefluor^pos but not Tp1:eGFP^pos cells, while eGFP is detected in Tp1:eGFP^pos but not Aldefluor^pos cells. Arrows in (C) indicate low-abundance Aldh1-sorted cells present in Tp1:eGFP^neg but not Tp1:eGFP^pos cell fraction. E, RT-PCR analysis of gene expression in FACS sorting populations. Positive and negative populations of cells sorted for either Aldh1 activity or Tp1:eGFP expression displayed differential expression of aldh1a2, prom1, and sca1, with contrasting patterns of enrichment in Aldefluor^pos vs. Aldefluor^neg and Tp1:eGFP^pos vs. Tp1:eGFP^neg cell fractions, further documenting the non-overlapping nature of Aldh1-expressing and Notch-responsive progenitor cells. Note that both populations are depleted of transcripts encoding differentiated endocrine (insulin), acinar (elastase1) and ductal (krt18) markers.